This transformative gift from Ted W. Love, M.D., and Joyce Y. Love will improve patient care for those with sickle cell disease on a local and international level.

Sickle cell disease is the most common and clinically significant inherited blood disorder across the nation, and now there is an FDA-approved gene therapy to help those living with SCD.

The NIH grant will advance efforts to reduce the gap between research and care of sickle cell disease.

Although unproven, this novel sickle cell therapy serves as a potential cure. More measures need to be taken to determine long-term function and organ improvement.

UAB’s Julie Kanter, M.D., says statewide surveillance programs for sickle cell disease can help facilitate progress to improve outcomes.